troleandomycin has been researched along with Migraine Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, CD; Dworetzky, S; Fitzpatrick, WC; Harden, D; He, H; Knox, RJ; Newton, AE; Philip, T; Polson, C; Sinz, MW; Sivarao, DV; Sun, LQ; Tertyshnikova, S; Weaver, D; Wu, YJ; Yeola, S; Zoeckler, M | 1 |
| Havill, JH; Matthews, NT | 1 |
| Hayton, AC | 1 |
3 other study(ies) available for troleandomycin and Migraine Disorders
| Article | Year |
|---|---|
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibiti
Topics: Administration, Oral; Animals; Biological Availability; Cell Line; Cinnamates; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Fluorine; Injections, Intravenous; Ion Channel Gating; KCNQ2 Potassium Channel; Male; Membrane Potentials; Migraine Disorders; Morpholines; Parietal Lobe; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2003 |
Ergotism with therapeutic doses of ergotamine tartrate.
Topics: Adult; Drug Interactions; Ergotamines; Ergotism; Female; Humans; Middle Aged; Migraine Disorders; Nitroprusside; Troleandomycin | 1979 |
Precipitation of acute ergotism by triacetyloleandomycin.
Topics: Adult; Ergotamine; Ergotism; Humans; Liver; Male; Migraine Disorders; Tartrates; Troleandomycin | 1969 |